arrow
J

Julio Bobes

Biomedical Research Networking Centre in Mental Health
H指数:74
被引数:3.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prolonged Childhood and Adolescent Loneliness in First-Episode Psychosis: Synergistic Polygenic Effects and Functional Outcomes

首发精神分裂症患者童年期和青春期孤独感的延长:多基因协同效应与功能结局

2026-08-240
PRE
Polygenic liability to loneliness increases psychosis risk through adolescent loneliness: evidence from the EU-GEI study

多基因易感性增加孤独症风险,通过青少年孤独:来自EU-GEI研究的证据

2026-07-280
OA
Biological underpinnings and genetic predisposition to schizophrenia within microrna-137 regulatory pathways across brain development

精神分裂症的生物学基础及其在脑发育过程中microRNA-137调控通路内的遗传易感性

2026-02-110
OAAI
Clinical predictors and psychosocial risk factors of suicide attempt severity

自杀未遂严重程度的临床预测因子和心身社会危险因素

2025-09-016
OAAI
DNA methylation patterns and epigenetic aging associated with suicide attempts in bipolar disorder

与双相障碍自杀未遂相关的DNA甲基化模式和表观遗传衰老

2025-08-240
PREAI
Comparative analysis of gut microbiome-derived short-chain fatty acids in patients with severe mental disorder: Insights from schizophrenia and bipolar disorder

重度精神障碍患者肠道菌群衍生短链脂肪酸的对比分析:来自精神分裂症和双相障碍的见解

2025-04-010
PRE
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors

通过病前恶化和暴露于环境危险因素,在精神病发作时的认知表现

2025-02-050
PRE
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case-Control Analysis from the First Episode Case-Control EU-GEI WP2 Study: L'arrêt de l'utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l'étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques

停止使用大麻和精神障碍的风险: 来自第一集病例对照eu-gei WP2研究的病例对照分析: l'arr ê tde l'utilisation du Cannabis et le risque de situes psychotiques: 分析cas-témoins tirée de l'étude cas-témoins eu-gei WP2 centrée sur les premiers é p psychotiques

2025-01-150
PRE
The role of childhood maltreatment and mental health disorders on suicidal behaviour in adolescents

儿童期虐待和精神卫生障碍对青少年自杀行为的影响

2025-01-010
PRE
Polygenic and Polyenvironment Interplay in Schizophrenia-Spectrum Disorder and Affective Psychosis; the EUGEI First Episode Study

精神分裂症谱系障碍和情感性精神病中的多基因和多环境相互作用; EUGEI第一集研究

2024-12-101
OAAI
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies

在eu-gei病例对照和英国Biobank研究中,精神分裂症遗传负荷和大量使用大麻对精神病风险的影响

2024-12-060
OAAI
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings
2024-11-220
OAAI
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study

在不同的欧洲环境中,亚临床精神病的变化与人口密度的关系: 来自多国eu-gei研究的发现

2024-11-010
PRE
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis

多基因风险评分和儿童逆境对首发精神病的跨诊断症状维度的影响: 精神病情感途径的证据

2024-10-260
OAAI
Methylomic signature of current cannabis use in two first-episode psychosis cohorts

在两个首发精神病队列中当前使用大麻的甲基特征

2024-10-160
OAAI
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial

首发精神分裂症谱系障碍的阳性和阴性综合征量表的维度结构: 来自OPTiMiSE试验的探索性图表分析

2024-09-302
OAAI